|
RNF141 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.00229999247625E-09 |
| Normal-vs-Stage3 |
5.13669999868682E-08 |
| Normal-vs-Stage4 |
4.70440353339541E-11 |
| Stage1-vs-Stage2 |
2.541400E-01 |
| Stage1-vs-Stage3 |
1.449370E-01 |
| Stage1-vs-Stage4 |
4.414000E-01 |
| Stage2-vs-Stage3 |
8.923800E-01 |
| Stage2-vs-Stage4 |
1.837790E-01 |
| Stage3-vs-Stage4 |
9.513500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.68065561467756E-12 |
| Normal-vs-Asian |
2.12779999999579E-05 |
| Caucasian-vs-AfricanAmerican |
2.896600E-01 |
| Caucasian-vs-Asian |
5.525000E-01 |
| AfricanAmerican-vs-Asian |
8.483200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.66519997790715E-09 |
| Male-vs-Female |
3.54320000000019E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.55351295663786E-14 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.26565424807268E-14 |
| Normal-vs-Extreme_Obese |
5.83210035820514E-10 |
| Normal_Weight-vs-Extreme_Weight |
2.252200E-01 |
| Normal_Weight-vs-Obese |
4.850800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.457600E-01 |
| Extreme_Weight-vs-Obese |
3.012000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.193600E-01 |
| Obese-vs-Extreme_Obese |
1.778010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.601560E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.39300015966626E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.437600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.221200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.535800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.195200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.097800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.964800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.62647673107585E-12 |
| Normal-VS-KIRP CIMP |
4.842500E-02 |
| Normal-VS-Unclassified PRCC |
1.75890000009282E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.286200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.306100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.466300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.809700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.131000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.076800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
8.81489999993157E-07 |
| Normal-vs-N2 |
4.15990000002253E-07 |
| N0-vs-N1 |
7.898200E-02 |
| N0-vs-N2 |
3.436800E-01 |
| N1-vs-N2 |
1.466820E-01 |
|
|
